
GC31997
5-Lipoxygenase-In-1
Also known as 1-ethyl-3-[4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl]-5,5-dimethyl-2-sulfanylideneimidazolidin-4-one
5-Lipoxygenase-In-1 is a 5-Lipoxygenase inhibitor extracted from patent EP 331232 A2, table 4, compound example 4·10
ChemicalCAS125235-15-6MW424.56FormulaC23H28N4O2S
- CAS number
- 125235-15-6
- Molecular weight
- 424.56
- Formula
- C23H28N4O2S
- Solubility
- DMSO: 250 mg/mL (588·84 mM)
- InChIKey
- AHWDHLCCXRVAIC-UHFFFAOYSA-N
- Catalogue number
- GC31997
- Brand
- GLPBIO
Computed properties PubChem CID 132150 · XLogP 3.8 · TPSA 82.4 Ų · H-bond donors 1
- XLogP
- 3.8
- TPSA
- 82.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 30
SMILES CCN1C(=S)N(C(=O)C1(C)C)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)O
Computed descriptors from PubChem (CID 132150), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il